For full functionality of this website it is necessary to enable JavaScript. Here are the instructions how to enable JavaScript in your web browser

Speaker Details

Ivana Knezevic Team Leader World Health Organization Geneva, Geneve Switzerland


"Position: Scientist, Technical Standards and Specifications Unit; Group Lead, Norms and Standards for Biologicals; Health Product Policy and Standards Department (HPS); Access to Medicines and Health Products Division (MHP); World Health Organization (WHO), Switzerland.

Dr Knezevic is Specialist in Medical Microbiology and Parasitology. She received her MD from the University of Novi Sad, MSc in Medicine (Microbiology) and PhD in Medicine (Virology) from the University of Belgrade, Republic of Serbia. Dr Ivana Knezevic has 30 years of professional experience in standardization, scientific and regulatory overview of biologicals. 

Dr Knezevic joined WHO in September 2000, and since then her activities have been devoted to the standardization and evaluation of biologicals at the global level. Since 2006, she has been leading the team for standardization of vaccines and biological therapeutics in WHO Headquarters. Dr Knezevic is the Secretary of the WHO Expert Committee on Biological Standardization. Main aspects of her work include development and establishment of WHO International Standards as well as the assistance to regulators, manufacturers, academia and other users of these standards. 

Being responsible for 8 WHO Collaborating centers for standardization and evaluation of vaccines and other biologicals, Dr Knezevic initiated numerous scientific projects of importance for global public health. In 2012, she created a network of the Collaborating centers that are playing a leading scientific and regulatory role in their countries as well as at the global level (UK, Japan, Australia, USA, Republic of Korea, Canada, China and Germany). 

Dr Knezevic is the author of many publications that made broad audience aware of WHO initiative in the development, establishment and implementation of standards for vaccines, biotherapeutics and cell & gene therapy products. She is also contributing to the peer-review scientific journals with the international reputation. 
"